Xarelto (rivaroxaban) is a prescription blood thinner that was developed by pharmaceutical giant Bayer, and marketed by Janssen Pharmaceuticals, a division of another pharmaceutical giant, Johnson & Johnson. Xarelto is typically prescribed to reduce the risks of suffering a stroke or blood clot in patients who have a heart rhythm…
Updated: